These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 7789484

  • 1. Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia.
    Rizzato G, Montemurro L, Fraioli P, Montanari G, Fanti D, Pozzoli R, Magliano E.
    Eur Respir J; 1995 Mar; 8(3):398-402. PubMed ID: 7789484
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.
    Bohte R, van't Wout JW, Lobatto S, Blussé van Oud Alblas A, Boekhout M, Nauta EH, Hermans J, van den Broek PJ.
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):182-7. PubMed ID: 7614957
    [Abstract] [Full Text] [Related]

  • 7. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
    Tamm M, Todisco T, Feldman C, Garbino J, Blasi F, Hogan P, de Caprariis PJ, Hoepelman IM.
    Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
    Griffin AT, Peyrani P, Wiemken T, Arnold F.
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309
    [Abstract] [Full Text] [Related]

  • 10. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?
    Sánchez F, Mensa J, Martínez JA, García E, Marco F, González J, Marcos MA, Soriano A, Torres A.
    Clin Infect Dis; 2003 May 15; 36(10):1239-45. PubMed ID: 12746768
    [Abstract] [Full Text] [Related]

  • 11. Etiology and treatment of community-acquired pneumonia in ambulatory children.
    Wubbel L, Muniz L, Ahmed A, Trujillo M, Carubelli C, McCoig C, Abramo T, Leinonen M, McCracken GH.
    Pediatr Infect Dis J; 1999 Feb 15; 18(2):98-104. PubMed ID: 10048679
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of a three-day course of azithromycin in the treatment of community-acquired pneumococcal pneumonia. Preliminary report.
    Uzun O, Hayran M, Akova M, Gür D, Akalin HE.
    J Chemother; 1994 Feb 15; 6(1):53-7. PubMed ID: 8071680
    [Abstract] [Full Text] [Related]

  • 19. An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
    Skrepnek GH, Armstrong EP, Malone DC, Ramachandran S.
    Curr Med Res Opin; 2005 Feb 15; 21(2):261-70. PubMed ID: 15801997
    [Abstract] [Full Text] [Related]

  • 20. The efficacy and tolerance of a three-day course of azithromycin in the treatment of community-acquired pneumonia.
    Myburgh J, Nagel GJ, Petschel E.
    J Antimicrob Chemother; 1993 Jun 15; 31 Suppl E():163-9. PubMed ID: 8396088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.